270 related articles for article (PubMed ID: 32922488)
21. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
22. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
23. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
[TBL] [Abstract][Full Text] [Related]
24. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
[TBL] [Abstract][Full Text] [Related]
25. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
Sharma PK; Chauhan MK
Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
[No Abstract] [Full Text] [Related]
26. A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment.
Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Buheazah TM; AlHomoud HS; Al-Nasif HA; Alam MA
Saudi J Biol Sci; 2020 Sep; 27(9):2344-2357. PubMed ID: 32884416
[TBL] [Abstract][Full Text] [Related]
27. PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study.
Sah AK; Suresh PK; Verma VK
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-9. PubMed ID: 27389068
[TBL] [Abstract][Full Text] [Related]
28. Formulation of PPAR-gamma agonist as surface modified PLGA nanoparticles for non-invasive treatment of diabetic retinopathy:
Laddha UD; Kshirsagar SJ
Heliyon; 2020 Aug; 6(8):e04589. PubMed ID: 32832706
[TBL] [Abstract][Full Text] [Related]
29. Clarithromycin-Loaded Poly (Lactic-
Öztürk AA; Yenilmez E; Özarda MG
Polymers (Basel); 2019 Oct; 11(10):. PubMed ID: 31600969
[TBL] [Abstract][Full Text] [Related]
30. Formulation and evaluation of butenafine loaded PLGA-nanoparticulate laden chitosan nano gel.
Alshehri S; Imam SS
Drug Deliv; 2021 Dec; 28(1):2348-2360. PubMed ID: 34747275
[TBL] [Abstract][Full Text] [Related]
31. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
32. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
33. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
35. Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation.
Salama AH; AbouSamra MM; Awad GEA; Mansy SS
Drug Deliv Transl Res; 2021 Oct; 11(5):1943-1957. PubMed ID: 33006742
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design.
Ghasemian E; Vatanara A; Rouholamini Najafabadi A; Rouini MR; Gilani K; Darabi M
Daru; 2013 Dec; 21(1):68. PubMed ID: 24355133
[TBL] [Abstract][Full Text] [Related]
37. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration.
Abdullah TA; Ibrahim NJ; Warsi MH
Int J Pharm Investig; 2016; 6(2):96-105. PubMed ID: 27051629
[TBL] [Abstract][Full Text] [Related]
38. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
39. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
[TBL] [Abstract][Full Text] [Related]
40. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]